Invest in innovations that can transform clinical outcomes.
VentureHealth™ is a portal for accredited investors who want investment access to breakthrough innovations in the $2.5 trillion healthcare sector.
Can Robotic Pills Replace Injections?
(From The Wall Street Journal)The adage "Take two aspirin and call me in the morning" is destined for a futuristic makeover. Doctors may just as easily recommend swallowing sophisticated gadgets instead. That is the hope of prolific inventor Mir Imran, who has created a robotic pill to replace injectable drugs for chronic conditions such as diabetes.
We raised $1.49M for Nfocus, which was acquired by Covidien in 2013.
This company was developing breakthrough solutions for neurovascular disease, which could change the standard of care for brain aneurysms. Covidien acquired Nfocus in 2013 based on preliminary data from its first human trial.
VentureHealth™ raises $2.6M for Rani Therapeutics, in a Series B, led by Google Ventures
Rani Therapeutics is developing technology to deliver biotherapeutics orally, removing the need for subcutaneous or intramuscular injections. The company has delivered a well-known, commercially available antibody in a pre-clinical model.
We raised $1.8M for the world's next billion-dollar blockbuster, now partnered with St. Jude Medical.
Spinal Modulation is already changing the way that pain is treated by blocking it at the dorsal root ganglia. Now growing rapidly in Europe, the company has demonstrated dramatic improvements in managing chronic, intractable pain even in challenging anatomical points, such as the foot.
Bodymedia acquired by Jawbone, maker of the Up and Jambox
BodyMedia pioneered the development of wearable body monitors that collect physiological data for use in improving health, wellness and fitness. The company is now a subsidiary of Jawbone.
